Entrada Therapeutics Inc (TRDA)

Healthcare Pharmaceuticals & Medical Research Biotechnology & Medical Research

Track Share on 𝕏

Stock chart
Ticker: TRDA Exchange: NMS


Subscribe to get access to the transaction volume chart and in-chart transaction details
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale
Past 90 days
 
Value bought
 
Value sold
 
Net insiders buying
 
Trades (buy and sell)
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PS: Planned sale, O: Option / Other
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Total value Details
2024-05-10 2024-05-09 B Purchase

KIM PETER S

Non-Executive Director
1,000 +3.4%
14.25
100,000 USD 		1,000 +3.4% 14.25 100,000 USD
2024-05-10 2024-05-08 B Purchase

KIM PETER S

Non-Executive Director
1,000 +3.6%
14.04
100,000 USD 		1,000 +3.6% 14.04 100,000 USD
2024-04-10 2024-04-08 B Purchase

KIM PETER S

Non-Executive Director
2,600 +4.3%
13.57
35,290 USD 		2,600 +4.3% 13.57 35,290 USD
2024-04-01 2024-03-28 B Purchase

KIM PETER S

Non-Executive Director
1,512 +2.6%
13.75
20,794 USD 		1,512 +2.6% 13.75 20,794 USD
2024-03-26 2024-03-26 B Purchase

KIM PETER S

Non-Executive Director
2,750 +4.9%
13.64
37,509 USD 		2,750 +4.9% 13.64 37,509 USD
2024-03-26 2024-03-25 B Purchase

KIM PETER S

Non-Executive Director
3,180 +6.0%
13.36
42,472 USD 		3,180 +6.0% 13.36 42,472 USD
2024-03-26 2024-03-22 B Purchase

KIM PETER S

Non-Executive Director
3,118 +6.3%
13.76
42,901 USD 		3,118 +6.3% 13.76 42,901 USD
2024-03-21 2024-03-21 B Purchase

KIM PETER S

Non-Executive Director
704 +1.4%
13.24
9,318 USD 		704 +1.4% 13.24 9,318 USD
2024-03-21 2024-03-20 B Purchase

KIM PETER S

Non-Executive Director
1,128 +2.4%
12.66
14,281 USD 		1,128 +2.4% 12.66 14,281 USD
2024-03-21 2024-03-19 B Purchase

KIM PETER S

Non-Executive Director
900 +1.9%
12.66
11,397 USD 		900 +1.9% 12.66 11,397 USD
2024-03-08 2024-03-06 PS Planned sale

WENTWORTH KORY JAMES

Chief Financial Officer

Officer
4,086 -5.2%
12.31
50,285 USD 		4,086 -5.2% 12.31 50,285 USD
2024-03-08 2024-03-06 PS Planned sale

Dowden Nathan J

President & COO

Officer
1,826 -1.3%
12.32
22,499 USD 		1,826 -1.3% 12.32 22,499 USD
2024-02-20 2024-02-15 PS Planned sale

Doshi Dipal

CEO

Executive Director
1,000 -0.4%
15.00
15,000 USD 		1,000 -0.4% 15.00 15,000 USD
2024-01-18 2024-01-16 PS Planned sale

Doshi Dipal

CEO

Executive Director
1,000 -0.4%
15.99
15,990 USD 		1,000 -0.4% 15.99 15,990 USD
2023-12-26 2023-12-26 PS Planned sale

WENTWORTH KORY JAMES

Chief Financial Officer

Officer
94 -0.2%
16.67
1,567 USD 		94 -0.2% 16.67 1,567 USD
2023-12-26 2023-12-22 PS Planned sale

WENTWORTH KORY JAMES

Chief Financial Officer

Officer
3,677 -6.9%
16.48
60,611 USD 		3,677 -6.9% 16.48 60,611 USD
2023-12-26 2023-12-22 PS Planned sale

WENTWORTH KORY JAMES

Chief Financial Officer

Officer
6,529 -10.9%
15.24
99,513 USD 		6,529 -10.9% 15.24 99,513 USD
2023-12-26 2023-12-21 PS Planned sale

WENTWORTH KORY JAMES

Chief Financial Officer

Officer
2,200 -4.2%
15.07
33,155 USD 		2,200 -4.2% 15.07 33,155 USD
2023-12-22 2023-12-20 PS Planned sale

Doshi Dipal

President and CEO

Executive Director
1,000 -0.4%
15.00
15,000 USD 		1,000 -0.4% 15.00 15,000 USD
2023-11-13 2023-11-13 PS Planned sale

Doshi Dipal

President and CEO

Executive Director
1,000 -0.4%
16.23
16,230 USD 		1,000 -0.4% 16.23 16,230 USD
2023-10-19 2023-10-17 PS Planned sale

Doshi Dipal

President and CEO

Executive Director
1,000 -0.4%
15.00
15,000 USD 		1,000 -0.4% 15.00 15,000 USD
2023-09-15 2023-09-13 PS Planned sale

Doshi Dipal

President and CEO

Executive Director
1,000 -0.4%
15.00
15,000 USD 		1,000 -0.4% 15.00 15,000 USD
2023-09-06 2023-09-06 PS Planned sale

Dowden Nathan J

Chief Operating Officer

Officer
59 -0.1%
14.01
826 USD 		59 -0.1% 14.01 826 USD
2023-09-06 2023-09-06 PS Planned sale

Dowden Nathan J

Chief Operating Officer

Officer
913 -1.9%
13.43
12,263 USD 		913 -1.9% 13.43 12,263 USD
2023-09-06 2023-09-06 PS Planned sale

KREHER NERISSA

Chief Medical Officer

Officer
21 -0.1%
14.00
294 USD 		21 -0.1% 14.00 294 USD
2023-09-06 2023-09-06 PS Planned sale

KREHER NERISSA

Chief Medical Officer

Officer
871 -2.1%
13.46
11,728 USD 		871 -2.1% 13.46 11,728 USD
2023-09-06 2023-09-06 PS Planned sale

WENTWORTH KORY JAMES

Chief Financial Officer

Officer
46 -0.1%
14.03
645 USD 		46 -0.1% 14.03 645 USD
2023-09-06 2023-09-06 PS Planned sale

WENTWORTH KORY JAMES

Chief Financial Officer

Officer
904 -1.8%
13.45
12,161 USD 		904 -1.8% 13.45 12,161 USD
2023-08-16 2023-08-14 PS Planned sale

Doshi Dipal

President and CEO

Executive Director
1,000 -0.5%
15.67
15,671 USD 		1,000 -0.5% 15.67 15,671 USD
2023-08-04 2023-08-04 PS Planned sale

KREHER NERISSA

Chief Medical Officer

Officer
6,898 -20.3%
14.14
97,521 USD 		6,898 -20.3% 14.14 97,521 USD
2023-08-04 2023-08-03 PS Planned sale

KREHER NERISSA

Chief Medical Officer

Officer
9,464 -25.9%
14.74
139,530 USD 		9,464 -25.9% 14.74 139,530 USD
2023-08-04 2023-08-02 PS Planned sale

KREHER NERISSA

Chief Medical Officer

Officer
68 -0.3%
16.82
1,144 USD 		68 -0.3% 16.82 1,144 USD
2023-08-04 2023-08-02 PS Planned sale

KREHER NERISSA

Chief Medical Officer

Officer
1,000 -3.5%
16.01
16,012 USD 		1,000 -3.5% 16.01 16,012 USD
2023-08-04 2023-08-02 PS Planned sale

KREHER NERISSA

Chief Medical Officer

Officer
9,280 -24.8%
15.09
140,013 USD 		9,280 -24.8% 15.09 140,013 USD
2023-07-12 2023-07-11 PS Planned sale

Dowden Nathan J

Chief Operating Officer

Officer
3,897 -9.9%
18.05
70,333 USD 		3,897 -9.9% 18.05 70,333 USD
2023-07-12 2023-07-11 PS Planned sale

WENTWORTH KORY JAMES

Chief Financial Officer

Officer
3,884 -9.6%
18.00
69,904 USD 		3,884 -9.6% 18.00 69,904 USD
2023-07-12 2023-07-11 PS Planned sale

Sethuraman Natarajan

Chief Scientific Officer

Officer
14,852 -8.8%
18.04
267,915 USD 		14,852 -8.8% 18.04 267,915 USD
2023-07-12 2023-07-10 PS Planned sale

Dowden Nathan J

Chief Operating Officer

Officer
3,200 -7.5%
18.00
57,605 USD 		3,200 -7.5% 18.00 57,605 USD
2023-07-12 2023-07-10 PS Planned sale

WENTWORTH KORY JAMES

Chief Financial Officer

Officer
6,116 -14.3%
17.98
109,958 USD 		6,116 -14.3% 17.98 109,958 USD
2023-07-12 2023-07-10 PS Planned sale

Sethuraman Natarajan

Chief Scientific Officer

Officer
3,026 -1.8%
18.00
54,474 USD 		3,026 -1.8% 18.00 54,474 USD
2023-06-22 2023-06-22 PS Planned sale

Dowden Nathan J

Chief Operating Officer

Officer
7,097 -14.3%
16.02
113,700 USD 		7,097 -14.3% 16.02 113,700 USD
2023-06-23 2023-06-21 PS Planned sale

WENTWORTH KORY JAMES

Chief Financial Officer

Officer
8,907 -24.2%
15.17
135,129 USD 		8,907 -24.2% 15.17 135,129 USD
2023-06-23 2023-06-21 PS Planned sale

WENTWORTH KORY JAMES

Chief Financial Officer

Officer
8,593 -18.9%
14.84
127,519 USD 		8,593 -18.9% 14.84 127,519 USD
2023-06-22 2023-06-20 PS Planned sale

Dowden Nathan J

Chief Operating Officer

Officer
8,885 -15.2%
14.94
132,704 USD 		8,885 -15.2% 14.94 132,704 USD
2023-05-01 2023-04-27 PS Planned sale

Doshi Dipal

President and CEO

Executive Director
2,000 -1.0%
13.71
27,422 USD 		2,000 -1.0% 13.71 27,422 USD
2023-04-19 2023-04-17 PS Planned sale

Sethuraman Natarajan

Chief Scientific Officer

Officer
3,961 -2.3%
18.00
71,316 USD 		3,961 -2.3% 18.00 71,316 USD
2023-04-19 2023-04-17 PS Planned sale

Doshi Dipal

President and CEO

Executive Director
2,092 -1.0%
18.01
37,675 USD 		2,092 -1.0% 18.01 37,675 USD
2023-03-29 2023-03-27 PS Planned sale

Doshi Dipal

President and CEO

Executive Director
200 -0.1%
15.51
3,102 USD 		200 -0.1% 15.51 3,102 USD
2023-03-29 2023-03-27 PS Planned sale

Doshi Dipal

President and CEO

Executive Director
1,800 -0.7%
14.63
26,333 USD 		1,800 -0.7% 14.63 26,333 USD
2023-03-03 2023-03-02 PS Planned sale

KREHER NERISSA

Chief Medical Officer

Officer
164 -0.4%
11.22
1,841 USD 		164 -0.4% 11.22 1,841 USD
2023-03-03 2023-03-02 PS Planned sale

KREHER NERISSA

Chief Medical Officer

Officer
1,477 -3.4%
10.49
15,496 USD 		1,477 -3.4% 10.49 15,496 USD
2023-03-03 2023-03-02 PS Planned sale

WENTWORTH KORY JAMES

Chief Financial Officer

Officer
145 -0.3%
11.23
1,628 USD 		145 -0.3% 11.23 1,628 USD
2023-03-03 2023-03-02 PS Planned sale

WENTWORTH KORY JAMES

Chief Financial Officer

Officer
1,602 -3.6%
10.46
16,761 USD 		1,602 -3.6% 10.46 16,761 USD
2023-03-02 2023-02-28 PS Planned sale

Doshi Dipal

President and CEO

Executive Director
2,000 -1.2%
12.00
24,000 USD 		2,000 -1.2% 12.00 24,000 USD
2023-01-30 2023-01-27 PS Planned sale

Doshi Dipal

President and CEO

Executive Director
2,000 -1.2%
12.00
24,001 USD 		2,000 -1.2% 12.00 24,001 USD
2023-01-10 2023-01-09 PS Planned sale

Doshi Dipal

President and CEO

Executive Director
2,410 -1.4%
15.02
36,196 USD 		2,410 -1.4% 15.02 36,196 USD
2023-01-03 2022-12-30 PS Planned sale

KREHER NERISSA

Chief Medical Officer

Officer
5,200 -25.1%
13.45
69,932 USD 		5,200 -25.1% 13.45 69,932 USD
2022-12-29 2022-12-29 PS Planned sale

Doshi Dipal

President and CEO

Executive Director
400 -0.2%
15.01
6,005 USD 		400 -0.2% 15.01 6,005 USD
2022-12-29 2022-12-28 PS Planned sale

Doshi Dipal

President and CEO

Executive Director
4,521 -2.6%
15.01
67,852 USD 		4,521 -2.6% 15.01 67,852 USD
2022-12-29 2022-12-27 PS Planned sale

Doshi Dipal

President and CEO

Executive Director
9,069 -5.0%
15.04
136,383 USD 		9,069 -5.0% 15.04 136,383 USD
2022-12-29 2022-12-27 PS Planned sale

Doshi Dipal

President and CEO

Executive Director
600 -0.3%
14.80
8,879 USD 		600 -0.3% 14.80 8,879 USD
2022-12-12 2022-12-08 PS Planned sale

WENTWORTH KORY JAMES

Chief Financial Officer

Officer
4,550 -21.6%
18.95
86,238 USD 		4,550 -21.6% 18.95 86,238 USD
2022-12-06 2022-12-05 PS Planned sale

WENTWORTH KORY JAMES

Chief Financial Officer

Officer
200 -1.2%
18.05
3,610 USD 		200 -1.2% 18.05 3,610 USD
2022-12-06 2022-12-02 PS Planned sale

WENTWORTH KORY JAMES

Chief Financial Officer

Officer
2,910 -15.0%
18.20
52,949 USD 		2,910 -15.0% 18.20 52,949 USD
2022-11-30 2022-11-28 PS Planned sale

Doshi Dipal

President and CEO

Executive Director
2,000 -1.1%
13.91
27,826 USD 		2,000 -1.1% 13.91 27,826 USD
2022-11-18 2022-11-16 PS Planned sale

WENTWORTH KORY JAMES

Chief Financial Officer

Officer
200 -1.2%
18.10
3,620 USD 		200 -1.2% 18.10 3,620 USD
2022-11-02 2022-10-31 PS Planned sale

Dowden Nathan J

Chief Operating Officer

Officer
2,100 -4.4%
24.05
50,495 USD 		2,100 -4.4% 24.05 50,495 USD
2022-10-27 2022-10-27 PS Planned sale

Doshi Dipal

President and CEO

Executive Director
2,000 -1.1%
21.66
43,325 USD 		2,000 -1.1% 21.66 43,325 USD
2022-10-27 2022-10-26 PS Planned sale

KREHER NERISSA

Chief Medical Officer

Officer
4,317 -17.2%
22.01
95,021 USD 		4,317 -17.2% 22.01 95,021 USD
2022-10-27 2022-10-26 PS Planned sale

KREHER NERISSA

Chief Medical Officer

Officer
643 -2.5%
21.21
13,638 USD 		643 -2.5% 21.21 13,638 USD
2022-10-27 2022-10-25 PS Planned sale

Doshi Dipal

President and CEO

Executive Director
1,500 -0.8%
21.50
32,251 USD 		1,500 -0.8% 21.50 32,251 USD
2022-10-27 2022-10-25 PS Planned sale

Doshi Dipal

President and CEO

Executive Director
7,506 -3.8%
20.76
155,808 USD 		7,506 -3.8% 20.76 155,808 USD
2022-10-27 2022-10-25 PS Planned sale

Doshi Dipal

President and CEO

Executive Director
3,055 -1.5%
20.01
61,127 USD 		3,055 -1.5% 20.01 61,127 USD
2022-10-27 2022-10-25 PS Planned sale

Dowden Nathan J

Chief Operating Officer

Officer
900 -1.9%
21.85
19,669 USD 		900 -1.9% 21.85 19,669 USD
2022-10-27 2022-10-25 PS Planned sale

Dowden Nathan J

Chief Operating Officer

Officer
5,414 -10.1%
20.97
113,526 USD 		5,414 -10.1% 20.97 113,526 USD